Dupilumab produces dramatic improvement in atopic dermatitis

The monoclonal antibody dupilumab, which blocks the action of the type 2 helper T-cell (Th2) cytokines interleukin-4 and interleukin-13, produced rapid and significant improvement in all signs,...